Curative embolization of ruptured pediatric cerebral arteriovenous malformations

Aaron Rodriguez-Calienes1, Juan Vivanco-Suarez2, Nagheli Fernanda Borjas-Calderón3

  • 1Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA; Neuroscience, Clinical Effectiveness and Public Health Research Group, Universidad Científica del Sur, Lima, Peru.

Insights

Curative embolization of pediatric ruptured arteriovenous malformations (AVMs) shows moderate obliteration rates but carries risks of recurrence and complications. Lesions under 2 cm are more amenable to complete obliteration via endovascular management.

Area of Science:

  • Vascular Surgery
  • Pediatric Neurology
  • Interventional Radiology

Background:

  • Curative embolization for ruptured arteriovenous malformations (AVMs) is not extensively studied, particularly in pediatric cases.
  • The efficacy and safety of primary curative embolization for pediatric AVMs remain uncertain.

Purpose of the Study:

  • To evaluate the safety and efficacy of curative embolization in pediatric patients with ruptured AVMs.
  • To identify predictors of successful obliteration and procedure-related complications.

Main Methods:

  • Retrospective analysis of pediatric patients (≤18 years) undergoing curative embolization for ruptured AVMs between 2010 and 2022.
  • Assessment of complete angiographic obliteration, recurrence rates, and safety outcomes (complications, mortality).

Main Results:

  • Complete angiographic obliteration was achieved in 62% of 68 pediatric patients after a median follow-up of 18 months.
  • Recurrence occurred in 13% of cases, with 11.9% experiencing procedure-related complications; no deaths were reported.
  • Nidus size > 2 cm was the sole independent predictor of incomplete obliteration (OR = 0.16; p = 0.030).

Conclusions:

  • Curative embolization offers acceptable obliteration rates for pediatric ruptured AVMs but requires careful consideration of recurrence and complications.
  • Pediatric ruptured AVMs ≤ 2 cm demonstrate suitability for complete obliteration through curative endovascular management.
Abstract